Testing for monogenic diabetes is lower than required to reveal its true prevalence in an Australian population

被引:3
作者
Ali, Aleena S. [1 ,2 ]
Wong, Jay C. S. [3 ]
Campbell, Ainsley [4 ]
Ekinci, Elif I. [1 ,2 ,5 ]
机构
[1] Austin Hlth, Dept Endocrinol, 300 Waterdale Rd, Heidelberg, Vic 3084, Australia
[2] Univ Melbourne, Melbourne Med Sch, Parkville, Vic, Australia
[3] Deakin Univ, Geelong, Vic, Australia
[4] Austin Hlth, Dept Clin Genet, 145 Studley Rd, Heidelberg, Vic, Australia
[5] Univ Melbourne, Australian Ctr Accelerating Diabet Innovat ACADI, Parkville, Australia
来源
DIABETES EPIDEMIOLOGY AND MANAGEMENT | 2022年 / 6卷
关键词
Monogenic diabetes; MODY; Maturity-onset diabetes of the young; Genetics; GENE-MUTATIONS; YOUNG MODY; DIAGNOSIS; INSULIN; HNF1A;
D O I
10.1016/j.deman.2022.100069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Monogenic diabetes is responsible for 1-5% of all cases of diabetes. A previous Australian study estimated a prevalence of 89 cases per million adults, or one in 280 people with diabetes. Approximately 80% of monogenic diabetes is misdiagnosed as type 1 or type 2 diabetes. Our aims were: 1. To estimate the incidence of referral for genetic testing for monogenic diabetes at an Australian tertiary hospital. 2. To estimate the proportion of individuals with confirmed monogenic diabetes out of those who are referred for genetic testing. 3. To investigate the clinical, biochemical and genetic characteristics of patients with confirmed monogenic diabetes in an Australian population. Methods: We conducted a retrospective audit of patients referred to the genetics service at Austin Health for testing for monogenic diabetes from August 2018 to January 2021, inclusive. We collected pre-existing clinical, biochemical and genetic data from electronic medical records from patients with both confirmed and suspected monogenic diabetes. Results: Of approximately 2576 referrals to the diabetes clinic at Austin Health between December 2018 and January 2021, 46 individuals (1.8%, 95% CI 1.3-2.3%) were referred for genetic testing. Of the individuals referred for testing, 16 (35%, 95% CI 23-49%) declined testing and 3 (6.5%, 95% CI 2.2-18%) did not proceed with genetic testing due to their clinician identifying this as low-yield. Of the 27 individuals who were tested, ten individuals had a positive genetic test result (37%, 95% CI 22-58%) and 1 (2.1%, 95% CI 0.38-11%) had a variant of uncertain significance. GCK variants were the most common variant detected. Conclusion: Approximately 0.39% (95% CI 0.21-0.71) of people seen in the diabetes clinics at a tertiary centre were diagnosed with monogenic diabetes over a period of 26 months. (c) 2022 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:5
相关论文
共 23 条
[1]   Treatment implications of a delayed diagnosis of maturity-onset diabetes of the young [J].
Ali, Aleena S. ;
Brown, Fran ;
Ekinci, Elif, I .
INTERNAL MEDICINE JOURNAL, 2021, 51 (01) :116-120
[2]  
[Anonymous], 2021, Invitae Monogenic Diabetes Panel
[3]   Glucokinase Deficit Prevalence in Women With Diabetes in Pregnancy: A Matter of Screening Selection [J].
Bitterman, Olimpia ;
Giuliani, Chiara ;
Festa, Camilla ;
Napoli, Angela .
FRONTIERS IN ENDOCRINOLOGY, 2020, 11
[4]   Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study [J].
Carlsson, Annelie ;
Shepherd, Maggie ;
Ellard, Sian ;
Weedon, Michael ;
Lernmark, Ake ;
Forsander, Gun ;
Colclough, Kevin ;
Brahimi, Qefsere ;
Valtonen-Andre, Camilla ;
Ivarsson, Sten A. ;
Elding Larsson, Helena ;
Samuelsson, Ulf ;
Ortqvist, Eva ;
Groop, Leif ;
Ludvigsson, Johnny ;
Marcus, Claude ;
Hattersley, Andrew T. .
DIABETES CARE, 2020, 43 (01) :82-89
[5]   The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase II [J].
Davis, Timothy M. E. ;
Makepeace, Ashley E. ;
Ellard, Sian ;
Colclough, Kevin ;
Peters, Kirsten ;
Hattersley, Andrew ;
Davis, Wendy A. .
MEDICAL JOURNAL OF AUSTRALIA, 2017, 207 (08) :344-347
[6]   Insulin mutation screening in 1,044 patients with diabetes:: Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood [J].
Edghill, Emma L. ;
Flanagan, Sarah E. ;
Patch, Ann-Marie ;
Boustred, Chris ;
Parrish, Andrew ;
Shields, Beverley ;
Shepherd, Maggie H. ;
Hussain, Khalid ;
Kapoor, Ritika R. ;
Malecki, Maciej ;
MacDonald, Michael J. ;
Stoy, Julie ;
Steiner, Donald F. ;
Philipson, Louis H. ;
Bell, Graeme I. ;
Hattersley, Andrew T. ;
Ellard, Sian .
DIABETES, 2008, 57 (04) :1034-1042
[7]  
Espoo Finland, 2022, Blueprint genetics
[8]   Comprehensive genetic screening: The prevalence of maturity-onset diabetes of the young gene variants in a population-based childhood diabetes cohort [J].
Johnson, Stephanie R. ;
Ellis, Jonathan J. ;
Leo, Paul J. ;
Anderson, Lisa K. ;
Ganti, Uma ;
Harris, Jessica E. ;
Curran, Jacqueline A. ;
McInerney-Leo, Aideen M. ;
Paramalingam, Nirubasini ;
Song, Xiaoxia ;
Conwell, Louise S. ;
Harris, Mark ;
Jones, Timothy W. ;
Brown, Matthew A. ;
Davis, Elizabeth A. ;
Duncan, Emma L. .
PEDIATRIC DIABETES, 2019, 20 (01) :57-64
[9]   Undiagnosed MODY: Time for Action [J].
Kleinberger, Jeffrey W. ;
Pollin, Toni I. .
CURRENT DIABETES REPORTS, 2015, 15 (12)
[10]   Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes [J].
McDonald, T. J. ;
Colclough, K. ;
Brown, R. ;
Shields, B. ;
Shepherd, M. ;
Bingley, P. ;
Williams, A. ;
Hattersley, A. T. ;
Ellard, Sian .
DIABETIC MEDICINE, 2011, 28 (09) :1028-1033